|
View the NDEWS Weekly Briefing Issue 289 ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
|
| |
This Week's Focus: 5th Annual NDEWS Summit at the 2026 College on Problems of Drug Dependence (CPDD)
|
|
|
| |
The 5th Annual NDEWS Summit convened this week in Portland, Oregon, in conjunction with the 88th Annual College on Problems of Drug Dependence. NDEWS Sentinel Site Directors, Scientific Advisors, Community Based Health Experts, members of the Coordinating Center, affiliates, NIDA leadership and interested scientists spent four hours (even during the Knicks vs Spurs game) updating each other on emerging drugs and other trends in their areas.
Anecdotally, we heard people thought it was the best Summit yet, but stay tuned for a survey! To extend this enthusiasm, we focus this week’s NDEWS Weekly Briefing on the science we presented. But first, we thank CPDD for letting us meet ahead of the meeting and look forward to being in Toronto, Canada, next year. SAVE THE DATE for the next Summit on June 26th, 2027, in tandem with the first day of the CPDD meeting, June 26 to 30, 2027.
Those of us who have been going to CPDD, whether it was our first time or our 34th time, enjoyed our time there. In the Briefing today, we share the topics presented by our NDEWS extended family.
As always, we welcome your input.
|
|
|
|
| |
Presentations from the NDEWS family at CPDD
|
|
|
| |
Safety of intravenous methamphetamine in patients taking mirtazapine: A two-site phase 1b randomized controlled trial
Late-Breaking Abstract: NDEWS Sentinel Site Director Phillip Coffin presented original research on the safety of mirtazapine, a potential treatment for methamphetamine use disorder.
|
|
|
|
|
| |
Charaterizing the relationship between nonmedical use of gabapentin and gabapentin prescribing in opioid use disorder treatment
Poster: NDEWS Scientific Advisory Group Chair Matthew Ellis presented original research on the increase in gabapentin prescriptions and nonmedical use Sunday afternoon.
|
|
|
|
|
| |
In the Pitt: Addiction treatment in emergency department settings
Oral Presentation: NDEWS Community Based Health Expert Alyssa Falise presented "Role of Age on Route of Administration Among ED Patients with non-fatal opioid overdose" during a session she chaired Monday, June 15.
|
|
|
|
|
| |
Changing rates of use of psilocybin over time as reported in NDEWS Rapid Street Reporting
Poster: NDEWS staff member and admin coordinator Tamara Millay presented her poster Monday, June 15, that analyzed changes in reported rates of use of psilocybin over time in cities visited by the NDEWS Rapid Street Reporting team on more than one occasion.
|
|
|
|
|
| |
How many fentanyl overdose deaths are among people with unintentional, or otherwise non-regular use of fentanyl
Poster: NDEWS Sentinel Site Director Phillip Coffin presented research on seeking a means to determine intentionality of pre-mortem fentanyl use through a simple method to estimate absence of regular fentanyl use using norfentanyl.
|
|
|
|
|
| |
Tracking evolving drug supply dynamics in the US: Insights from an Early Warning Network
Poster: NDEWS staff member and project coordinator Emmely Pavila presented a poster Monday, June 15, summarizing significant shifts in the drug landscape and associated harms using data gathered from the NDEWS network.
|
|
|
|
|
| |
Enhancing fatal overdose surveillance with historic emergency medical service encounter data in Kentucky
Poster: NDEWS Sentinel Site Director Sarah Hargrove presented a poster that featured research describing how novel historic encounter data from Emergency Medical Services (EMS) can be used to enhance contextual findings related to fatal drug overdose events.
|
|
|
|
|
| |
The current landscape of adulterants in the illicit drug supply: An NDEWS/CFSRE update
Invited Symposium: NDEWS Co-Director Joseph Palamar along with NDEWS & NIDA T32 Alumn Nicole Fitzgerald presented research on the current drug landscape and resulting drug-related harms that have rapidly shifted in recent years.
|
|
|
|
|
| |
Overdose prevention centers and other harm reduction services in Latin American cities: An update on novel developments and challenges
Symposium: NDEWS Sentinel Site Director Annick Borquez co-chaired a symposium that explored the landscape of harm reduction services in Los Angeles, and the impact of specific programs implemented in Colombia, Brasil and
Mexico.
|
|
|
|
|
| |
The challenges and benefits of studying polysubstance use
Symposium: NDEWS Director Linda Cottler concluded CPDD on Wednesday, June 17, with her presentation on "How to assess polysubstance use in humans: Challenges and best practices."
|
|
|
|
|
| |
Florida Department of Health issues warning on dangerous opioid-like products sold in stores across Florida
|
|
|
| |
A recent alert issued by the Florida Department of Health is warning Floridians about the serious health risks associated with 7-hydroxymitragynine (7-OH) and its derivatives, potent opioid-like compounds that are increasingly being marketed and sold throughout Florida.
Read the full alert from the Florida Department of Health here. |
|
|
|
| |
Join the UF T32 Training Program in Substance Abuse and Public Health as a Pre or Postdoc! Work with the NDEWS Team!
|
|
|
| |
Are you committed to advancing the science of substance use and public health? The University of Florida’s NIDA-funded T32 Training Program offers predoctoral and postdoctoral scholars an exceptional opportunity to launch impactful research careers focused on NDEWS!
What We Offer:
- Interdisciplinary training at the intersection of addiction science, epidemiology, and surveillance
- Mentorship from leading UF faculty in epidemiology, public health, psychology, medicine, and more
- Hands-on research with landmark and important NIH-funded projects and access to rich data
- Career development support, including grant writing, publishing, and professional networking
- A collaborative, inclusive research community committed to reducing the burden of substance use
Eligibility:
- US citizens or permanent residents
- Interested in a PhD in Epidemiology, or early-stage postdoctoral fellows
- Demonstrated interest in substance use, addiction, or public health research
Location: Gainesville, Florida — a dynamic hub for scientific innovation with high quality of life and low cost of living.
|
|
|
| |
The NDEWS Weekly Briefing curates emerging data and findings from across the Early Warning Network, which includes three core components: our Scientific Advisory Group (SAG), comprised of national experts and federal partners; our Sentinel Site Directors (SSDs), who lead local surveillance in key geographic regions; and our Community-Based Health Experts, who provide on-the-ground insights from populations most impacted by drug trends. Together, these contributors generate timely, multidisciplinary and impactful information, ranging from peer-reviewed research findings to local surveillance data. These contributions inform public health and research communities.
|
|
|
| |
You can share the NDEWS Weekly Briefing with friends, colleagues, and others who would benefit from information on recent and relevant news, articles, and data related to novel drug trends in the US and globally by clicking here. |
|
|
| |
The Weekly Briefing is a newsletter published each week by the National Drug Early Warning System (NDEWS) Coordinating Center, which is funded by the National Institute on Drug Abuse (U01DA051126) to the University of Florida (MPI: Cottler (contact), Co-Is: Goldberger, Nixon, Striley), NYU Langone Health (MPI: Palamar), and Florida Atlantic University (Co-I: Barenholtz). Any item may be reproduced provided the source is acknowledged.
|
|
|
